Inventories - Schedule of Inventories (Details) - USD ($) |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Inventories [Abstract] | ||
| Medicines, consumables and reagents for clinical and laboratory analyses | $ 93,302 | $ 77,296 |
| Supplements | 258,064 | 258,064 |
| Total inventories | $ 351,366 | $ 335,360 |
| X | ||||||||||
- Definition Amoun of supplements. No definition available.
|
| X | ||||||||||
- Definition Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|